CHWY Chewy | $35.03
-5.2% | 2/4/2025 | Target Set by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $42.00 | Low | View details for Guggenheim rating of Chewy (NYSE:CHWY) on 2/4/2025 |
ZVRA Zevra Therapeutics | $7.68
-1.9% | 2/4/2025 | Target Set by | Guggenheim | Analyst E. Hickman | Buy -> Buy | $21.00 | Low | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 2/4/2025 |
VG Venture Global | $15.29
-7.6% | 2/18/2025 | Initiated by | Guggenheim | Analyst S. Pourreza | Buy | $27.00 | High | View details for Guggenheim rating of Venture Global (NYSE:VG) on 2/18/2025 |
PCG PG&E | $15.94
+1.6% | 2/18/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Low | View details for Guggenheim rating of PG&E (NYSE:PCG) on 2/18/2025 |
NKE NIKE | $76.50
-0.9% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $110.00 -> $110.00 | Low | View details for Guggenheim rating of NIKE (NYSE:NKE) on 2/12/2025 |
CPRI Capri | $21.36
-2.2% | 2/12/2025 | Reiterated by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for Guggenheim rating of Capri (NYSE:CPRI) on 2/12/2025 |
MRUS Merus | $47.37
-0.5% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 2/12/2025 |
UTL Unitil | $56.23
-0.8% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $55.00 -> $55.00 | High | View details for Guggenheim rating of Unitil (NYSE:UTL) on 2/12/2025 |
AN AutoNation | $181.19
-4.2% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | | Low | View details for Guggenheim rating of AutoNation (NYSE:AN) on 2/12/2025 |
MRK Merck & Co., Inc. | $89.40
+2.0% | 2/12/2025 | Target Lowered by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $122.00 -> $115.00 | Low | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 2/12/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
TDC Teradata | $23.34
-2.4% | 2/12/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $42.00 -> $37.00 | High | View details for Guggenheim rating of Teradata (NYSE:TDC) on 2/12/2025 |
CFLT Confluent | $31.01
-4.7% | 2/12/2025 | Target Raised by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $35.00 -> $38.00 | High | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 2/12/2025 |
OS Onestream | $24.68
+2.0% | 2/12/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $35.00 -> $35.00 | High | View details for Guggenheim rating of Onestream (NASDAQ:OS) on 2/12/2025 |
ARVN Arvinas | $17.77
-3.3% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $57.00 -> $57.00 | High | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 2/12/2025 |
EXEL Exelixis | $36.85
+5.0% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $42.00 -> $42.00 | High | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 2/12/2025 |
FLNC Fluence Energy | $6.94
-5.7% | 2/11/2025 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Sell | $26.00 -> $6.00 | High | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 2/11/2025 |
SNAP Snap | $10.35
-3.1% | 2/11/2025 | Downgraded by | Guggenheim | Analyst M. Morris | Buy -> Neutral | | Medium | View details for Guggenheim rating of Snap (NYSE:SNAP) on 2/11/2025 |
RZLT Rezolute | $4.53
-2.2% | 2/10/2025 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | | Low | View details for Guggenheim rating of Rezolute (NASDAQ:RZLT) on 2/10/2025 |
TARS Tarsus Pharmaceuticals | $47.84
-1.8% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | | Medium | View details for Guggenheim rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/10/2025 |
APGE Apogee Therapeutics | $34.55
+1.8% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Low | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 2/10/2025 |
ARQT Arcutis Biotherapeutics | $13.02
-3.0% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 2/10/2025 |
ORIC ORIC Pharmaceuticals | $7.68
+2.8% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/10/2025 |
ES Eversource Energy | $63.41
+0.0% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | | High | View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 2/10/2025 |
CNTA Centessa Pharmaceuticals | $16.63
-0.7% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 2/10/2025 |
IMVT Immunovant | $21.26
+4.0% | 2/10/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $46.00 -> $44.00 | High | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 2/10/2025 |
NBIX Neurocrine Biosciences | $120.69
+3.9% | 2/10/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $165.00 -> $163.00 | High | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/10/2025 |
PFE Pfizer | $26.32
+1.6% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $33.00 -> $33.00 | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 2/10/2025 |
RL Ralph Lauren | $277.92
-3.0% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $285.00 -> $310.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 2/7/2025 |
INSM Insmed | $81.06
-3.0% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $95.00 -> $101.00 | Low | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 2/7/2025 |
KR Kroger | $65.03
+1.0% | 2/7/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $68.00 -> $71.00 | Low | View details for Guggenheim rating of Kroger (NYSE:KR) on 2/7/2025 |
TPR Tapestry | $84.60
-2.2% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $70.00 -> $90.00 | Low | View details for Guggenheim rating of Tapestry (NYSE:TPR) on 2/7/2025 |
FTNT Fortinet | $110.02
-3.7% | 2/7/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Fortinet (NASDAQ:FTNT) on 2/7/2025 |
LESL Leslie's | $1.42
-4.1% | 2/7/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Neutral -> Neutral | | High | View details for Guggenheim rating of Leslie’s (NASDAQ:LESL) on 2/7/2025 |
WMG Warner Music Group | $35.26
-0.9% | 2/7/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 2/7/2025 |
UAA Under Armour | $7.09
-1.0% | 2/7/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Under Armour (NYSE:UAA) on 2/7/2025 |
CMS CMS Energy | $71.49
+1.1% | 2/7/2025 | Reiterated by | Guggenheim | Analyst S. Pourreza | Neutral -> Neutral | $69.00 -> $69.00 | Medium | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 2/7/2025 |
ORLY O'Reilly Automotive | $1,303.41
-0.7% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $1,400.00 -> $1,475.00 | Medium | View details for Guggenheim rating of O’Reilly Automotive (NASDAQ:ORLY) on 2/7/2025 |
NET Cloudflare | $151.83
-2.9% | 2/7/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Sell -> Sell | $57.00 -> $68.00 | High | View details for Guggenheim rating of Cloudflare (NYSE:NET) on 2/7/2025 |
PINS Pinterest | $37.68
-4.8% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Neutral -> Neutral | $33.00 -> $39.00 | High | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 2/7/2025 |
ILMN Illumina | $94.20
-3.1% | 2/7/2025 | Target Lowered by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $170.00 -> $150.00 | High | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 2/7/2025 |
DOGE To DO List (Ad) Elon's found so much waste he's now claiming "the magnitude of the fraud in federal entitlements" is greater than "the combined sum of every private scam you've ever heard by FAR"...
And while this is disturbing and even infuriating to see our tax money literally wasted... there IS a solution.
I believe it's Elon's ultimate end game. I'll walk you through it here. |
FOXA FOX | $56.95
-0.7% | 2/5/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $55.00 -> $60.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 2/5/2025 |
SPOT Spotify Technology | $606.98
-4.7% | 2/5/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $520.00 -> $675.00 | Medium | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 2/5/2025 |
NJR New Jersey Resources | $46.85
+0.9% | 2/5/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $53.00 -> $54.00 | Medium | View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 2/5/2025 |
LEVI Levi Strauss & Co. | $18.41
-1.4% | 2/3/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $20.00 -> $22.00 | Low | View details for Guggenheim rating of Levi Strauss & Co. (NYSE:LEVI) on 2/3/2025 |
JNJ Johnson & Johnson | $162.35
+1.7% | 2/3/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | $162.00 -> $166.00 | Low | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 2/3/2025 |
ABBV AbbVie | $202.03
+0.6% | 2/3/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $212.00 -> $214.00 | High | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 2/3/2025 |
CROX Crocs | $107.60
-1.2% | 2/3/2025 | Target Lowered by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $155.00 -> $150.00 | High | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 2/3/2025 |
CFLT Confluent | $31.01
-4.7% | 1/31/2025 | Target Raised by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $32.00 -> $35.00 | Medium | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 1/31/2025 |
INFA Informatica | $19.35
-2.4% | 1/31/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $37.00 -> $37.00 | Medium | View details for Guggenheim rating of Informatica (NYSE:INFA) on 1/31/2025 |
DECK Deckers Outdoor | $146.48
-2.4% | 1/31/2025 | Reiterated by | Guggenheim | Analyst R. Drbul | Neutral -> Neutral | | High | View details for Guggenheim rating of Deckers Outdoor (NYSE:DECK) on 1/31/2025 |
TSCO Tractor Supply | $56.37
-2.4% | 1/31/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 1/31/2025 |
CHKP Check Point Software Technologies | $216.80
-1.0% | 1/31/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/31/2025 |
DT Dynatrace | $59.79
-2.4% | 1/31/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 1/31/2025 |
ENPH Enphase Energy | $64.85
-2.0% | 1/31/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | $62.00 -> $62.00 | Medium | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 1/31/2025 |
TSLA Tesla | $337.80
-4.7% | 1/29/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | $175.00 -> $175.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 1/29/2025 |
NXT Nextracker | $46.12
-4.8% | 1/29/2025 | Target Raised by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $50.00 -> $62.00 | Low | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 1/29/2025 |
SIRI Sirius XM | $24.75
-1.7% | 1/29/2025 | Target Lowered by | Guggenheim | Analyst C. Baker | Buy -> Buy | $30.00 -> $29.00 | Medium | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 1/29/2025 |
RL Ralph Lauren | $277.92
-3.0% | 1/29/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $260.00 -> $285.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 1/29/2025 |
XIFR XPLR Infrastructure | $9.33
-0.2% | 1/29/2025 | Target Lowered by | Guggenheim | Analyst S. Pourreza | Neutral -> Neutral | $17.00 -> $12.00 | Low | View details for Guggenheim rating of XPLR Infrastructure (NYSE:XIFR) on 1/29/2025 |
SYY Sysco | $73.22
+2.8% | 1/29/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $85.00 -> $85.00 | Low | View details for Guggenheim rating of Sysco (NYSE:SYY) on 1/29/2025 |
CVLT Commvault Systems | $170.61
-7.7% | 1/29/2025 | Reiterated by | Guggenheim | Analyst H. Ma | Neutral -> Neutral | | Low | View details for Guggenheim rating of Commvault Systems (NASDAQ:CVLT) on 1/29/2025 |
ELDN Eledon Pharmaceuticals | $4.29
-1.2% | 1/28/2025 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $9.00 | High | View details for Guggenheim rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 1/28/2025 |
QSR Restaurant Brands International | C$88.62
-1.1% | 1/24/2025 | Upgraded by | Guggenheim | Analyst G. Francfort | Hold -> Strong-Buy | | N/A | View details for Guggenheim rating of Restaurant Brands International (TSE:QSR) on 1/24/2025 |
LEVI Levi Strauss & Co. | $18.41
-1.4% | 1/24/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $23.00 -> $23.00 | Low | View details for Guggenheim rating of Levi Strauss & Co. (NYSE:LEVI) on 1/24/2025 |
VSTM Verastem | $5.68
+2.0% | 1/24/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 1/24/2025 |
VIGL Vigil Neuroscience | $3.03
+4.8% | 1/24/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | High | View details for Guggenheim rating of Vigil Neuroscience (NASDAQ:VIGL) on 1/24/2025 |
UNP Union Pacific | $245.43
-0.9% | 1/24/2025 | Target Raised by | Guggenheim | Analyst Nathan Martin | Buy -> Buy | $266.00 -> $275.00 | Low | View details for Guggenheim rating of Union Pacific (NYSE:UNP) on 1/24/2025 |
TGNA TEGNA | $17.81
-1.9% | 1/24/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $22.00 -> $22.00 | Low | View details for Guggenheim rating of TEGNA (NYSE:TGNA) on 1/24/2025 |
MSFT Microsoft | $408.25
-1.9% | 1/24/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 1/24/2025 |
DYN Dyne Therapeutics | $14.01
+0.1% | 1/24/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | | Medium | View details for Guggenheim rating of Dyne Therapeutics (NASDAQ:DYN) on 1/24/2025 |
FTNT Fortinet | $110.02
-3.7% | 1/24/2025 | Reiterated by | Guggenheim | Analyst R. Mcdonough | Neutral -> Neutral | | Low | View details for Guggenheim rating of Fortinet (NASDAQ:FTNT) on 1/24/2025 |
CHKP Check Point Software Technologies | $216.80
-1.0% | 1/24/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/24/2025 |
ORLY O'Reilly Automotive | $1,303.41
-0.7% | 1/24/2025 | Target Raised by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $1,275.00 -> $1,400.00 | Low | View details for Guggenheim rating of O’Reilly Automotive (NASDAQ:ORLY) on 1/24/2025 |
QSR Restaurant Brands International | $62.26
-1.5% | 1/24/2025 | Upgraded by | Guggenheim | Analyst Gregory Francfort | Neutral -> Buy | $74.00 -> $71.00 | Low | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 1/24/2025 |
GEV GE Vernova | $327.68
-8.9% | 1/24/2025 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | $380.00 -> $380.00 | High | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 1/24/2025 |
SO Southern | $88.46
+0.7% | 1/23/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Low | View details for Guggenheim rating of Southern (NYSE:SO) on 1/23/2025 |
EIX Edison International | $52.10
+0.4% | 1/23/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Medium | View details for Guggenheim rating of Edison International (NYSE:EIX) on 1/23/2025 |
CMS CMS Energy | $71.49
+1.1% | 1/23/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Medium | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 1/23/2025 |
CNP CenterPoint Energy | $34.32
+1.8% | 1/23/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Low | View details for Guggenheim rating of CenterPoint Energy (NYSE:CNP) on 1/23/2025 |
NWE NorthWestern Energy Group | $53.92
+0.7% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Medium | View details for Guggenheim rating of NorthWestern Energy Group (NYSE:NWE) on 1/23/2025 |
IDA IDACORP | $113.98
+1.1% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Medium | View details for Guggenheim rating of IDACORP (NYSE:IDA) on 1/23/2025 |
EXC Exelon | $43.39
+0.5% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Low | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 1/23/2025 |
EVRG Evergy | $68.06
+1.2% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Low | View details for Guggenheim rating of Evergy (NASDAQ:EVRG) on 1/23/2025 |
DTE DTE Energy | $131.98
+0.6% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | High | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 1/23/2025 |
AEP American Electric Power | $105.33
+0.9% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Medium | View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 1/23/2025 |
NXST Nexstar Media Group | $149.56
-3.2% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | | Low | View details for Guggenheim rating of Nexstar Media Group (NASDAQ:NXST) on 1/22/2025 |
GH Guardant Health | $42.87
-9.6% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | | High | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 1/22/2025 |
FSLR First Solar | $155.39
-5.3% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $335.00 -> $335.00 | High | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 1/22/2025 |
DT Dynatrace | $59.79
-2.4% | 1/22/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 1/22/2025 |
EXEL Exelixis | $36.85
+5.0% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 1/22/2025 |
DOGE To DO List (Ad) Elon's found so much waste he's now claiming "the magnitude of the fraud in federal entitlements" is greater than "the combined sum of every private scam you've ever heard by FAR"...
And while this is disturbing and even infuriating to see our tax money literally wasted... there IS a solution.
I believe it's Elon's ultimate end game. I'll walk you through it here. |
IPSC Century Therapeutics | $0.73
-2.5% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Low | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 1/22/2025 |
DDOG Datadog | $119.67
-5.2% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Neutral -> Neutral | | Low | View details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 1/22/2025 |
NOW ServiceNow | $937.79
-3.1% | 1/22/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Sell -> Sell | $716.00 | Low | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 1/22/2025 |
NWSA News | $28.53
-1.1% | 1/22/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $40.00 -> $43.00 | Low | View details for Guggenheim rating of News (NASDAQ:NWSA) on 1/22/2025 |
TGT Target | $124.40
-2.9% | 1/22/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $145.00 -> $155.00 | Low | View details for Guggenheim rating of Target (NYSE:TGT) on 1/22/2025 |
NFLX Netflix | $1,003.15
-2.1% | 1/22/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $950.00 -> $1,100.00 | High | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 1/22/2025 |
PRGS Progress Software | $55.10
-2.6% | 1/17/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $83.00 -> $83.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 1/17/2025 |
BRKR Bruker | $50.82
-4.0% | 1/17/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | | Medium | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 1/17/2025 |
KROS Keros Therapeutics | $11.01
-0.2% | 1/17/2025 | Reiterated by | Guggenheim | Analyst V. Divan | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 1/17/2025 |
NTRA Natera | $162.31
-3.5% | 1/17/2025 | Target Raised by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $170.00 -> $200.00 | High | View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 1/17/2025 |
INFY Infosys | $21.17
-0.9% | 1/17/2025 | Reiterated by | Guggenheim | Analyst Jonathan Lee | Neutral -> Neutral | | Low | View details for Guggenheim rating of Infosys (NYSE:INFY) on 1/17/2025 |
LTH Life Time Group | $31.60
-3.1% | 1/17/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $29.00 -> $32.00 | High | View details for Guggenheim rating of Life Time Group (NYSE:LTH) on 1/17/2025 |
OTLK Outlook Therapeutics | $1.56
-4.9% | 1/17/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $12.00 -> $12.00 | High | View details for Guggenheim rating of Outlook Therapeutics (NASDAQ:OTLK) on 1/17/2025 |
NFLX Netflix | $1,003.15
-2.1% | 1/13/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $825.00 -> $950.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 1/13/2025 |
IGMS IGM Biosciences | $1.38
-0.7% | 1/10/2025 | Downgraded by | Guggenheim | Analyst M. Schmidt | Buy -> Neutral | | High | View details for Guggenheim rating of IGM Biosciences (NASDAQ:IGMS) on 1/10/2025 |
SWTX SpringWorks Therapeutics | $58.29
-2.7% | 1/8/2025 | Target Lowered by | Guggenheim | - | Buy -> Buy | $80.00 -> $78.00 | Medium | View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/8/2025 |
WMG Warner Music Group | $35.26
-0.9% | 1/8/2025 | Target Lowered by | Guggenheim | - | Buy -> Buy | $44.00 -> $40.00 | Medium | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 1/8/2025 |
PWR Quanta Services | $269.75
-4.1% | 1/8/2025 | Initiated by | Guggenheim | Analyst J. Osha | Neutral | | High | View details for Guggenheim rating of Quanta Services (NYSE:PWR) on 1/8/2025 |
PRIM Primoris Services | $66.06
-2.6% | 1/8/2025 | Initiated by | Guggenheim | Analyst J. Osha | Buy | $102.00 | Medium | View details for Guggenheim rating of Primoris Services (NASDAQ:PRIM) on 1/8/2025 |
MTZ MasTec | $126.35
-4.8% | 1/8/2025 | Initiated by | Guggenheim | Analyst J. Osha | Buy | $195.00 | Low | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 1/8/2025 |
EXEL Exelixis | $36.85
+5.0% | 1/7/2025 | Target Raised by | Guggenheim | - | Buy -> Buy | $33.00 -> $42.00 | Low | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 1/7/2025 |
WDAY Workday | $256.39
-2.0% | 1/6/2025 | Upgraded by | Guggenheim | Analyst J. Difucci | Sell -> Neutral | | N/A | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 1/6/2025 |
PANW Palo Alto Networks | $191.03
-3.9% | 1/6/2025 | Downgraded by | Guggenheim | Analyst J. Difucci | Neutral -> Sell | $130.00 -> $130.00 | N/A | View details for Guggenheim rating of Palo Alto Networks (NASDAQ:PANW) on 1/6/2025 |
MDB MongoDB | $273.26
-5.8% | 1/6/2025 | Upgraded by | Guggenheim | Analyst H. Ma | Neutral -> Buy | $300.00 -> $300.00 | N/A | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 1/6/2025 |
CRM Salesforce | $309.54
-2.8% | 1/6/2025 | Downgraded by | Guggenheim | Analyst J. Difucci | Neutral -> Sell | $247.00 -> $247.00 | N/A | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 1/6/2025 |
DT Dynatrace | $59.79
-2.4% | 1/6/2025 | Downgraded by | Guggenheim | Analyst J. Difucci | Buy -> Neutral | | N/A | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 1/6/2025 |
SRZN Surrozen | $11.20
-3.0% | 1/3/2025 | Upgraded by | Guggenheim | Analyst Y. Suneja | Neutral -> Buy | $45.00 -> $45.00 | N/A | View details for Guggenheim rating of Surrozen (NASDAQ:SRZN) on 1/3/2025 |
ACAD ACADIA Pharmaceuticals | $19.95
-1.7% | 1/3/2025 | Downgraded by | Guggenheim | Analyst Y. Suneja | Buy -> Neutral | $23.00 -> $20.00 | N/A | View details for Guggenheim rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 1/3/2025 |
SARTF Sartorius Aktiengesellschaft | $193.95
-0.1% | 12/19/2024 | Upgraded by | Guggenheim | Analyst S. Nambi | Strong-Buy | | N/A | View details for Guggenheim rating of Sartorius Aktiengesellschaft (OTCMKTS:SARTF) on 12/19/2024 |
RDDT Reddit | $166.27
-5.2% | 12/20/2024 | Initiated by | Guggenheim | Analyst M. Morris | Buy | $210.00 | N/A | View details for Guggenheim rating of Reddit (NYSE:RDDT) on 12/20/2024 |
KR Kroger | $65.03
+1.0% | 12/19/2024 | Initiated by | Guggenheim | - | Buy | $68.00 | N/A | View details for Guggenheim rating of Kroger (NYSE:KR) on 12/19/2024 |
BRKR Bruker | $50.82
-4.0% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $72.00 | N/A | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 12/19/2024 |
CYRX Cryoport | $6.22
-6.2% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $11.00 | N/A | View details for Guggenheim rating of Cryoport (NASDAQ:CYRX) on 12/19/2024 |
DHR Danaher | $209.86
+0.9% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $275.00 | N/A | View details for Guggenheim rating of Danaher (NYSE:DHR) on 12/19/2024 |
MRVI Maravai LifeSciences | $4.11
+4.1% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Neutral | | N/A | View details for Guggenheim rating of Maravai LifeSciences (NASDAQ:MRVI) on 12/19/2024 |
NEOG Neogen | $10.04
| 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $15.00 | N/A | View details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 12/19/2024 |
KROS Keros Therapeutics | $11.01
-0.2% | 12/16/2024 | Downgraded by | Guggenheim | Analyst V. Divan | Buy -> Neutral | | N/A | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 12/16/2024 |
RH RH | $340.06
-7.1% | 12/13/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $425.00 -> $550.00 | N/A | View details for Guggenheim rating of RH (NYSE:RH) on 12/13/2024 |
APGE Apogee Therapeutics | $34.55
+1.8% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 12/12/2024 |
ARVN Arvinas | $17.77
-3.3% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 12/12/2024 |
BWA BorgWarner | $29.49
-2.5% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $41.00 -> $41.00 | N/A | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 12/12/2024 |
ANAB AnaptysBio | $18.62
-1.3% | 12/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $90.00 -> $36.00 | N/A | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 12/12/2024 |
WBD Warner Bros. Discovery | $10.78
-2.4% | 12/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $11.00 -> $12.50 | N/A | View details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 12/12/2024 |
ADCT ADC Therapeutics | $1.64
-2.1% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 12/12/2024 |
LOW Lowe's Companies | $238.93
-3.0% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $300.00 -> $300.00 | N/A | View details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 12/12/2024 |
M Macy's | $15.00
-5.0% | 12/12/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Macy’s (NYSE:M) on 12/12/2024 |
SPRB Spruce Biosciences | $0.42
-1.2% | 12/12/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 12/12/2024 |
UNFI United Natural Foods | $31.68
-1.9% | 12/12/2024 | Reiterated by | Guggenheim | Analyst J. Heinbockel | Neutral -> Neutral | | N/A | View details for Guggenheim rating of United Natural Foods (NYSE:UNFI) on 12/12/2024 |
BPMC Blueprint Medicines | $92.25
-2.2% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Blueprint Medicines (NASDAQ:BPMC) on 12/11/2024 |
PEG Public Service Enterprise Group | $83.82
-1.0% | 12/11/2024 | Reiterated by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | | N/A | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 12/11/2024 |
DOGE To DO List (Ad) Elon's found so much waste he's now claiming "the magnitude of the fraud in federal entitlements" is greater than "the combined sum of every private scam you've ever heard by FAR"...
And while this is disturbing and even infuriating to see our tax money literally wasted... there IS a solution.
I believe it's Elon's ultimate end game. I'll walk you through it here. |
QURE uniQure | $12.84
-0.9% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of uniQure (NASDAQ:QURE) on 12/11/2024 |
TRML Tourmaline Bio | $12.21
-1.3% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Tourmaline Bio (NASDAQ:TRML) on 12/11/2024 |
AZO AutoZone | $3,366.15
-1.2% | 12/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3,350.00 -> $3,750.00 | N/A | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 12/11/2024 |
GEV GE Vernova | $327.68
-8.9% | 12/11/2024 | Target Lowered by | Guggenheim | Analyst J. Osha | Buy -> Buy | $400.00 -> $380.00 | N/A | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 12/11/2024 |
GIII G-III Apparel Group | $28.16
-2.4% | 12/11/2024 | Target Raised by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $36.00 -> $38.00 | N/A | View details for Guggenheim rating of G-III Apparel Group (NASDAQ:GIII) on 12/11/2024 |
PFE Pfizer | $26.32
+1.6% | 12/11/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $33.00 | N/A | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 12/11/2024 |
VFC VF | $25.49
-3.7% | 12/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $25.00 -> $27.00 | N/A | View details for Guggenheim rating of VF (NYSE:VFC) on 12/11/2024 |
SIRI Sirius XM | $24.75
-1.7% | 12/11/2024 | Reiterated by | Guggenheim | Analyst C. Baker | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 12/11/2024 |
QTTB Q32 Bio | $2.57
+5.8% | 12/11/2024 | Downgraded by | Guggenheim | Analyst Y. Suneja | Buy -> Neutral | | N/A | View details for Guggenheim rating of Q32 Bio (NASDAQ:QTTB) on 12/11/2024 |
TEM Tempus AI | $68.09
-11.2% | 12/9/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $74.00 | N/A | View details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 12/9/2024 |
TARA Protara Therapeutics | $3.72
-5.8% | 12/6/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for Guggenheim rating of Protara Therapeutics (NASDAQ:TARA) on 12/6/2024 |
CROX Crocs | $107.60
-1.2% | 12/6/2024 | Reiterated by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $155.00 -> $155.00 | N/A | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 12/6/2024 |
DLTR Dollar Tree | $74.96
-1.7% | 12/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $100.00 | N/A | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 12/6/2024 |
PVH PVH | $78.73
+0.1% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $105.00 -> $125.00 | N/A | View details for Guggenheim rating of PVH (NYSE:PVH) on 12/6/2024 |
RBRK Rubrik | $69.67
-3.5% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $52.00 -> $72.00 | N/A | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 12/6/2024 |
LULU Lululemon Athletica | $358.97
-1.9% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $350.00 -> $415.00 | N/A | View details for Guggenheim rating of Lululemon Athletica (NASDAQ:LULU) on 12/6/2024 |
FLNC Fluence Energy | $6.94
-5.7% | 12/6/2024 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $26.00 -> $26.00 | N/A | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 12/6/2024 |
TSLA Tesla | $337.80
-4.7% | 12/5/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $156.00 -> $175.00 | N/A | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 12/5/2024 |
S SentinelOne | $22.15
-2.8% | 12/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for Guggenheim rating of SentinelOne (NYSE:S) on 12/5/2024 |
APTV Aptiv | $66.65
-1.4% | 12/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $73.00 -> $73.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 12/5/2024 |
ORCL Oracle | $167.92
-4.6% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $200.00 -> $220.00 | N/A | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 12/5/2024 |
TJX TJX Companies | $121.08
-1.5% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $135.00 -> $140.00 | N/A | View details for Guggenheim rating of TJX Companies (NYSE:TJX) on 12/5/2024 |
FIVE Five Below | $85.92
-3.6% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $125.00 -> $140.00 | N/A | View details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 12/5/2024 |
FL Foot Locker | $18.22
-3.6% | 12/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $34.00 -> $28.00 | N/A | View details for Guggenheim rating of Foot Locker (NYSE:FL) on 12/5/2024 |
GEV GE Vernova | $327.68
-8.9% | 12/5/2024 | Target Raised by | Guggenheim | Analyst J. Osha | Buy -> Buy | $300.00 -> $400.00 | N/A | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 12/5/2024 |
RH RH | $340.06
-7.1% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $425.00 -> $425.00 | N/A | View details for Guggenheim rating of RH (NYSE:RH) on 12/4/2024 |
CRM Salesforce | $309.54
-2.8% | 12/4/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 12/4/2024 |
OKTA Okta | $92.75
-2.6% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $130.00 -> $130.00 | N/A | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 12/4/2024 |
WMG Warner Music Group | $35.26
-0.9% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $44.00 -> $44.00 | N/A | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 12/4/2024 |
BASE Couchbase | $17.90
-2.2% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 12/4/2024 |
KROS Keros Therapeutics | $11.01
-0.2% | 12/4/2024 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $96.00 -> $102.00 | N/A | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 12/4/2024 |
LYV Live Nation Entertainment | $149.37
-1.9% | 12/4/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $146.00 -> $155.00 | N/A | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 12/4/2024 |
AZO AutoZone | $3,366.15
-1.2% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 12/4/2024 |
SNAP Snap | $10.35
-3.1% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $12.11 -> $12.11 | N/A | View details for Guggenheim rating of Snap (NYSE:SNAP) on 12/3/2024 |
RVMD Revolution Medicines | $41.34
-2.2% | 12/3/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $82.00 -> $87.00 | N/A | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 12/3/2024 |
ABSI Absci | $4.96
-4.5% | 12/3/2024 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 12/3/2024 |
APGE Apogee Therapeutics | $34.55
+1.8% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $95.00 -> $110.00 | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 12/3/2024 |
BNTC Benitec Biopharma | $11.30
-2.3% | 12/3/2024 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for Guggenheim rating of Benitec Biopharma (NASDAQ:BNTC) on 12/3/2024 |
PRME Prime Medicine | $2.96
-5.4% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for Guggenheim rating of Prime Medicine (NYSE:PRME) on 12/3/2024 |
ZS Zscaler | $198.56
-4.1% | 12/3/2024 | Reiterated by | Guggenheim | - | Neutral | | N/A | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 12/3/2024 |
MRUS Merus | $47.37
-0.5% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $111.00 -> $109.00 | N/A | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 12/3/2024 |
KSS Kohl's | $12.03
+0.2% | 12/2/2024 | Downgraded by | Guggenheim | Analyst R. Drbul | Buy -> Neutral | | N/A | View details for Guggenheim rating of Kohl’s (NYSE:KSS) on 12/2/2024 |
BBY Best Buy | $89.80
-1.3% | 11/29/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $110.00 -> $105.00 | N/A | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 11/29/2024 |
APGE Apogee Therapeutics | $34.55
+1.8% | 11/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $95.00 -> $110.00 | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 11/27/2024 |
KSS Kohl's | $12.03
+0.2% | 11/27/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $26.00 -> $25.00 | N/A | View details for Guggenheim rating of Kohl’s (NYSE:KSS) on 11/27/2024 |
NJR New Jersey Resources | $46.85
+0.9% | 11/27/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $46.00 -> $49.00 | N/A | View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 11/27/2024 |
CPRI Capri | $21.36
-2.2% | 11/26/2024 | Upgraded by | Guggenheim | Analyst R. Drbul | Neutral -> Buy | $30.00 | N/A | View details for Guggenheim rating of Capri (NYSE:CPRI) on 11/26/2024 |
KR Kroger | $65.03
+1.0% | 11/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $61.00 -> $63.00 | N/A | View details for Guggenheim rating of Kroger (NYSE:KR) on 11/25/2024 |
NXT Nextracker | $46.12
-4.8% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 11/22/2024 |
ROST Ross Stores | $136.61
-1.8% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $180.00 -> $180.00 | N/A | View details for Guggenheim rating of Ross Stores (NASDAQ:ROST) on 11/22/2024 |
DOGE To DO List (Ad) Elon's found so much waste he's now claiming "the magnitude of the fraud in federal entitlements" is greater than "the combined sum of every private scam you've ever heard by FAR"...
And while this is disturbing and even infuriating to see our tax money literally wasted... there IS a solution.
I believe it's Elon's ultimate end game. I'll walk you through it here. |
WMG Warner Music Group | $35.26
-0.9% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $44.00 -> $44.00 | N/A | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 11/22/2024 |
CPK Chesapeake Utilities | $123.71
+0.0% | 11/22/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $118.00 -> $129.00 | N/A | View details for Guggenheim rating of Chesapeake Utilities (NYSE:CPK) on 11/22/2024 |
ESTC Elastic | $106.30
-3.0% | 11/22/2024 | Target Raised by | Guggenheim | Analyst H. Ma | Buy -> Buy | $100.00 -> $120.00 | N/A | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 11/22/2024 |
GAP GAP | $22.20
-0.9% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $35.00 -> $35.00 | N/A | View details for Guggenheim rating of GAP (NYSE:GAP) on 11/22/2024 |
SHLS Shoals Technologies Group | $4.52
-1.5% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $8.00 -> $7.00 | N/A | View details for Guggenheim rating of Shoals Technologies Group (NASDAQ:SHLS) on 11/21/2024 |
TGT Target | $124.40
-2.9% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $180.00 -> $145.00 | N/A | View details for Guggenheim rating of Target (NYSE:TGT) on 11/21/2024 |
AN AutoNation | $181.19
-4.2% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $190.00 -> $189.00 | N/A | View details for Guggenheim rating of AutoNation (NYSE:AN) on 11/21/2024 |
APTV Aptiv | $66.65
-1.4% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $87.00 -> $73.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 11/21/2024 |
GNTX Gentex | $24.37
-0.9% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $34.00 | N/A | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 11/21/2024 |
GPI Group 1 Automotive | $451.10
-3.7% | 11/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $420.00 -> $442.00 | N/A | View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 11/21/2024 |
LAD Lithia Motors | $350.44
-2.8% | 11/21/2024 | Target Raised by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $380.00 -> $418.00 | N/A | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 11/21/2024 |
WMT Walmart | $94.70
-2.6% | 11/20/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $100.00 | N/A | View details for Guggenheim rating of Walmart (NYSE:WMT) on 11/20/2024 |
JACK Jack in the Box | $38.46
-2.1% | 11/20/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $95.00 -> $60.00 | N/A | View details for Guggenheim rating of Jack in the Box (NASDAQ:JACK) on 11/20/2024 |
SEDG SolarEdge Technologies | $17.62
-3.1% | 11/20/2024 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | N/A | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 11/20/2024 |
RBRK Rubrik | $69.67
-3.5% | 11/19/2024 | Target Raised by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $48.00 -> $52.00 | N/A | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 11/19/2024 |
SBGI Sinclair | $14.50
-2.1% | 11/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $18.00 -> $19.00 | N/A | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 11/19/2024 |
FUN Cedar Fair | $45.13
-2.8% | 11/19/2024 | Target Raised by | Guggenheim | Analyst C. Baker | Buy -> Buy | $52.00 -> $55.00 | N/A | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 11/19/2024 |
IHRT iHeartMedia | $2.11
-3.2% | 11/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3.00 -> $5.00 | N/A | View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 11/19/2024 |
ADAP Adaptimmune Therapeutics | $0.56
-3.5% | 11/15/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $4.00 -> $3.00 | N/A | View details for Guggenheim rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 11/15/2024 |
CNTA Centessa Pharmaceuticals | $16.63
-0.7% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $24.00 -> $28.00 | N/A | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 11/15/2024 |
DIS Walt Disney | $108.62
-1.7% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $110.00 -> $130.00 | N/A | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 11/15/2024 |
TPR Tapestry | $84.60
-2.2% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $60.00 -> $70.00 | N/A | View details for Guggenheim rating of Tapestry (NYSE:TPR) on 11/15/2024 |
ZNTL Zentalis Pharmaceuticals | $2.32
-6.1% | 11/15/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $12.00 -> $8.00 | N/A | View details for Guggenheim rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/15/2024 |
GTN Gray Television | $3.82
-4.6% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $10.00 -> $8.00 | N/A | View details for Guggenheim rating of Gray Television (NYSE:GTN) on 11/12/2024 |
LYV Live Nation Entertainment | $149.37
-1.9% | 11/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $130.00 -> $146.00 | N/A | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 11/12/2024 |
SPHR Sphere Entertainment | $46.97
-0.9% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $49.00 -> $48.00 | N/A | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 11/12/2024 |
NWSA News | $28.53
-1.1% | 11/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $36.00 -> $40.00 | N/A | View details for Guggenheim rating of News (NASDAQ:NWSA) on 11/12/2024 |
PRKS United Parks & Resorts | $52.40
-3.3% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $72.00 -> $70.00 | N/A | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 11/12/2024 |
SMAR Smartsheet | $56.47
| 11/11/2024 | Downgraded by | Guggenheim | Analyst J. Difucci | Buy -> Neutral | | N/A | View details for Guggenheim rating of Smartsheet (NYSE:SMAR) on 11/11/2024 |
CDTX Cidara Therapeutics | $21.47
-4.1% | 11/8/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $33.00 | N/A | View details for Guggenheim rating of Cidara Therapeutics (NASDAQ:CDTX) on 11/8/2024 |
SIRI Sirius XM | $24.75
-1.7% | 11/6/2024 | Downgraded by | Guggenheim | Analyst C. Baker | Strong-Buy -> Hold | | N/A | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 11/6/2024 |
FOLD Amicus Therapeutics | $9.19
+1.3% | 11/7/2024 | Target Raised by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $13.00 -> $15.00 | N/A | View details for Guggenheim rating of Amicus Therapeutics (NASDAQ:FOLD) on 11/7/2024 |
PFGC Performance Food Group | $81.76
-3.3% | 11/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $95.00 | N/A | View details for Guggenheim rating of Performance Food Group (NYSE:PFGC) on 11/7/2024 |
SRPT Sarepta Therapeutics | $106.28
-2.0% | 11/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $148.00 -> $150.00 | N/A | View details for Guggenheim rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/7/2024 |
TNGX Tango Therapeutics | $2.36
-2.9% | 11/7/2024 | Target Lowered by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $18.00 -> $8.00 | N/A | View details for Guggenheim rating of Tango Therapeutics (NASDAQ:TNGX) on 11/7/2024 |
RUN Sunrun | $8.42
-1.4% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Sunrun (NASDAQ:RUN) on 11/7/2024 |
NOVA Sunnova Energy International | $1.95
-5.1% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 11/7/2024 |
ARRY Array Technologies | $6.59
-4.5% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 11/7/2024 |
JNJ Johnson & Johnson | $162.35
+1.7% | 11/6/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $156.00 -> $162.00 | N/A | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 11/6/2024 |
MRK Merck & Co., Inc. | $89.40
+2.0% | 11/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $137.00 -> $130.00 | N/A | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 11/6/2024 |
RIVN Rivian Automotive | $12.97
-4.7% | 11/6/2024 | Target Lowered by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $21.00 -> $18.00 | N/A | View details for Guggenheim rating of Rivian Automotive (NASDAQ:RIVN) on 11/6/2024 |
ABBV AbbVie | $202.03
+0.6% | 11/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $212.00 -> $221.00 | N/A | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 11/6/2024 |
DAVA Endava | $26.06
-7.9% | 11/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $45.00 -> $40.00 | N/A | View details for Guggenheim rating of Endava (NYSE:DAVA) on 11/6/2024 |
ITRI Itron | $93.94
-3.8% | 11/6/2024 | Target Raised by | Guggenheim | Analyst J. Osha | Buy -> Buy | $128.00 -> $135.00 | N/A | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 11/6/2024 |
FOXA FOX | $56.95
-0.7% | 11/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $50.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 11/5/2024 |
KTB Kontoor Brands | $88.01
-1.7% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $80.00 -> $100.00 | Medium | View details for Guggenheim rating of Kontoor Brands (NYSE:KTB) on 11/1/2024 |
ETR Entergy | $84.94
-1.1% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.50 -> $82.50 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 11/1/2024 |
KYMR Kymera Therapeutics | $36.81
-1.6% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $52.00 | Medium | View details for Guggenheim rating of Kymera Therapeutics (NASDAQ:KYMR) on 11/1/2024 |
ARGX argenx | $644.48
-0.5% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $585.00 -> $665.00 | High | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 11/1/2024 |
GSK GSK | $36.62
-0.9% | 10/31/2024 | Downgraded by | Guggenheim | Analyst S. Fernandez | Buy -> Neutral | | Medium | View details for Guggenheim rating of GSK (NYSE:GSK) on 10/31/2024 |
CROX Crocs | $107.60
-1.2% | 10/30/2024 | Target Lowered by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $182.00 -> $155.00 | Low | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 10/30/2024 |
EXEL Exelixis | $36.85
+5.0% | 10/30/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $32.00 -> $33.00 | Medium | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 10/30/2024 |
FSLR First Solar | $155.39
-5.3% | 10/30/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $368.00 -> $335.00 | Medium | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 10/30/2024 |
NFLX Netflix | $1,003.15
-2.1% | 10/29/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $810.00 -> $825.00 | N/A | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/29/2024 |
FUN Cedar Fair | $45.13
-2.8% | 10/29/2024 | Initiated by | Guggenheim | Analyst C. Baker | Buy | $52.00 | Medium | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 10/29/2024 |
GNLX Genelux | $4.84
+0.4% | 10/29/2024 | Initiated by | Guggenheim | Analyst K. Goodwin | Buy | $8.00 | Low | View details for Guggenheim rating of Genelux (NASDAQ:GNLX) on 10/29/2024 |
RL Ralph Lauren | $277.92
-3.0% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $200.00 -> $225.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 10/28/2024 |
PVH PVH | $78.73
+0.1% | 10/28/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $105.00 | Medium | View details for Guggenheim rating of PVH (NYSE:PVH) on 10/28/2024 |
WMT Walmart | $94.70
-2.6% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $81.00 -> $90.00 | Low | View details for Guggenheim rating of Walmart (NYSE:WMT) on 10/28/2024 |
VERA Vera Therapeutics | $28.58
-3.5% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $56.00 -> $64.00 | High | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 10/28/2024 |
